CXCL10 rs8878 identifies a genotype-associated immune phenotype linked to T-lymphocyte preservation and survival in sepsis - Summary - MDSpire

CXCL10 rs8878 as a Genetic Marker for Immune Phenotypes Associated with T-Lymphocyte Maintenance and Survival in Sepsis

  • By

  • Birte Dyck

  • Andrea Witowski

  • Thilo Bracht

  • Malte Bayer

  • Patrick Thon

  • Dominik Ziehe

  • Tim Rahmel

  • Matthias Unterberg

  • Britta Westhus

  • Lars Palmowski

  • Hartmuth Nowak

  • Stefan Felix Ehrentraut

  • Jennifer Orlowski

  • Alexander von Busch

  • Alexander Zarbock

  • Nina Babel

  • Moritz Anft

  • Dietrich Henzler

  • Michael Adamzik

  • Lars Bergmann

  • Barbara Sitek

  • Björn Koos

  • Katharina Rump

  • July 17, 2026

Share

Objective:

To investigate the association between CXCL10 rs8878 genotype, circulating T lymphocyte counts, and 30-day survival outcomes in septic patients.

Approach:
  • Study Design: A prospective cohort study involving 278 septic patients, analyzing CXCL10 rs8878 genotypes, immune cell counts, cytokine concentrations, and CXCL10 expression.
  • Data Analysis: Group comparisons, Kaplan-Meier analyses, and correlation analyses were performed to assess associations between genotype, immune parameters, and survival.
Key Findings:
  • CXCL10 rs8878 AA genotype carriers had higher circulating T cell counts and improved survival compared to G-allele carriers, based on statistical analyses.
  • Higher total and CD8+ T cell counts were significantly associated with improved survival, as determined by the study.
  • In non-survivors, AA-genotype carriers exhibited increased CXCL10 mRNA expression, indicating a potential link between genotype and immune response.
  • CXCL10 concentrations on day 1 correlated positively with several inflammatory cytokines and inversely with total T cell counts, suggesting a relationship between CXCL10 and immune dynamics.
Interpretation:

The CXCL10 rs8878 genotype is associated with T cell dynamics and 30-day survival in sepsis.

Limitations:
  • No significant associations were observed between CXCL10 genotype and plasma proteomics or routine clinical parameters.
Conclusion:

CXCL10 may serve as a biomarker for risk stratification in sepsis.

Original Source(s)

Related Content